Efficacy and safety of upadacitinib in a phase 2 randomized, double-blind, dose-ranging study of adults with extensive non-segmental vitiligo
BRITISH JOURNAL OF DERMATOLOGY(2024)
关键词
upadacitinib,non-segmental vitiligo,Janus kinase inhibitor,phase II
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要